Quantitative evaluation of the relative cell permeability of peptoids and peptides

Department of Internal Medicine and Division of Translational Research, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA.
Journal of the American Chemical Society (Impact Factor: 11.44). 03/2007; 129(6):1508-9. DOI: 10.1021/ja0668623
Source: PubMed

ABSTRACT We evaluated quantitatively the relative cell permeability of peptides and peptides using a cell-based reporter gene-based assay. Generally, peptoids were much more cell permeable than the corresponding peptides, though the difference decreased with increasing length. These results suggest that peptoids may be useful reagents for manipulating the activities of intracellular proteins.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The solution-phase synthesis and cyclisation of three α,β-peptoid octamers with differing side chain patterns is reported. One of these, compound C, showed a significantly greater resolution by NMR relative to the other two structurally related octamers. This observation was studied in detail by circular dichroism at a synchrotron light source to facilitate the correlation between the side chain patterns and conformational preference of these three peptoids. The X-ray crystal structure of cyclic octamer C, the first high-resolution structure for the α,β-peptoid backbone, was also obtained from methanol. Combined solid- and solution-phase studies allowed the identification of the N-2-(benzyloxy)ethyl side chain on the β-residue of the heterogeneous backbone as a key structural feature driving the increased conformational stability for octamer C.
    Amino Acids 04/2011; 41(3):663-72. DOI:10.1007/s00726-011-0887-1 · 3.65 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Non-invasive detection of vascular endothelial growth factor receptor 2 (VEGFR2) by positron emission tomography (PET) would allow the evaluation of tumor vascular activity in vivo. Recently, a dimeric peptoid, GU40C4, was reported as a highly potent antagonist of VEGFR2 activation inhibiting angiogenesis and tumor growth in vivo. The purpose of this work was to evaluate the potential of this peptoid for PET imaging of VEGFR2 expression. To label GU40C4 and a control peptoid with a positron emitter, (64)Cu (t(1/2) = 12.7 h; β(+): 0.653 MeV, 17.4%), a cysteine was introduced to the C-terminus of the peptoids and then conjugated to a bifunctional chelator (DOTA: 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) through the maleimide-thiol coupling chemistry. The in vitro binding assay showed a negligible effect of the DOTA conjugation on the VEGFR2 binding affinity of GU40C4. Both peptoid conjugates were efficiently labeled with (64)Cu in high radiochemical yields (> 90%); the specific activity was in the range of 10 - 80 GBq/μmol. PET imaging evaluation using a prostate cancer xenograft (PC3) mouse model showed that (64)Cu-DOTA-GU40C4 had a prominent and steady accumulation in the VEGFR2 positive PC3 tumors (2.25 ± 0.24, 2.15 ± 0.34, and 1.90 ± 0.18 %ID/g at 1, 4, and 20 h p.i., respectively; n = 3), which is significantly higher than the control peptoid conjugate (0.3 - 0.5 %ID/g; p < 0.001 at 1, 4, and 20 h p.i.). Interestingly, the mouse salivary glands were also clearly visualized by (64)Cu-DOTA-GU40C4 (3.17 ± 0.25, 3.00 ± 0.36, and 1.83 ± 0.21 %ID/g at 1, 4, and 20 h p.i., respectively; n = 3) rather than its control peptoid conjugate. VEGFR2 expression in the salivary glands was shown by polymerase chain reaction (PCR) assay. Our results demonstrate that (64)Cu-DOTA-GU40C4 can be used to image the expression of VEGFR2 in vivo.
    American Journal of Nuclear Medicine and Molecular Imaging 01/2011; 1(1):65-75. · 3.25 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Conventional constant modulus algorithms (CMAs) suffer shortcomings of slow convergence rate and possibility of improper convergence, which obstruct their application in real-time multiuser detection for CDMA cellular system. This paper focuses on developing new algorithms to alleviate these problems. Three new CMAs, recursive variable step size CMA, normalized constrained CMA and recursive variable step size constrained CMA, are obtained under a uniform framework. Interestingly they can be expressed in a general form. Since they automatically and adaptively choose the optimal variable step size there is no need to worry about whether the step size works and they converge much faster. To solve the modulus parameter sensitivity problem of constrained CMA, modulus parameter correction is integrated into RVSS-CCMA. Various simulations validate the efficiency and robustness of our new algorithms, especially the RVSS-CCMA with modulus parameter correction
    Vehicular Technology Conference, 2001. VTC 2001 Fall. IEEE VTS 54th; 02/2001


Available from